HOPO Therapeutics
HOPO Therapeutics
Home
About
Team
Careers
FAQ
Science
HOPO-101
Publications
Programs
Radiological Hazards
Lead Poisoning
Toxic Heavy Metals
News
Contact
chelation
Biomimetic Actinide Chelators: An Update on the Preclinical Development of the Orally Active Hydroxypyridonate Decorporation Agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)
Cite
×